BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 31078520)

  • 61. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
    An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
    Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
    Li Y; Gu J; Lu H
    Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
    Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2.
    Han H; Wang S; Meng J; Lyu G; Ding G; Hu Y; Wang L; Wu L; Yang W; Lv Y; Jia S; Zhang L; Ji J
    Oncogene; 2020 Oct; 39(42):6513-6528. PubMed ID: 32901105
    [TBL] [Abstract][Full Text] [Related]  

  • 65. MiR-216b regulates the tumorigenesis of gastric cancer by targeting PXN.
    Liu X; Xu D; Xu X; Xue Q; Gao X; Tang C
    Pathol Res Pract; 2021 Feb; 218():153325. PubMed ID: 33422779
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-28 promotes cell proliferation and invasion in gastric cancer via the PTEN/PI3K/AKT signalling pathway.
    Li L; Zhu X; Shou T; Yang L; Cheng X; Wang J; Deng L; Zheng Y
    Mol Med Rep; 2018 Mar; 17(3):4003-4010. PubMed ID: 29257342
    [TBL] [Abstract][Full Text] [Related]  

  • 68. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
    Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
    Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CircKIAA0907 Retards Cell Growth, Cell Cycle, and Autophagy of Gastric Cancer In Vitro and Inhibits Tumorigenesis In Vivo via the miR-452-5p/KAT6B Axis.
    Zhu L; Wang C; Lin S; Zong L
    Med Sci Monit; 2020 Jul; 26():e924160. PubMed ID: 32722658
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CISD2 enhances the chemosensitivity of gastric cancer through the enhancement of 5-FU-induced apoptosis and the inhibition of autophagy by AKT/mTOR pathway.
    Sun Y; Jiang Y; Huang J; Chen H; Liao Y; Yang Z
    Cancer Med; 2017 Oct; 6(10):2331-2346. PubMed ID: 28857517
    [TBL] [Abstract][Full Text] [Related]  

  • 71. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 73. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
    Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
    J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MicroRNA-936 promotes proliferation and invasion of gastric cancer cells by down-regulating FGF2 expression and activating P13K/Akt signaling pathway.
    Chen ZF; Wang J; Yu Y; Wei W
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6707-6715. PubMed ID: 32633361
    [TBL] [Abstract][Full Text] [Related]  

  • 75. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
    Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
    J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
    [TBL] [Abstract][Full Text] [Related]  

  • 76. LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway.
    Cheng L; Li X; Dong W; Yang J; Li P; Qiang X; Yin J; Guo L
    J Cancer Res Clin Oncol; 2024 May; 150(5):230. PubMed ID: 38703300
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance.
    Si W; Shen J; Du C; Chen D; Gu X; Li C; Yao M; Pan J; Cheng J; Jiang D; Xu L; Bao C; Fu P; Fan W
    Cell Death Differ; 2018 Feb; 25(2):406-420. PubMed ID: 29125598
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells.
    Wang Z; Wang Q; Xu G; Meng N; Huang X; Jiang Z; Chen C; Zhang Y; Chen J; Li A; Li N; Zou X; Zhou J; Ding Q; Wang S
    RNA Biol; 2020 Nov; 17(11):1576-1589. PubMed ID: 31885317
    [TBL] [Abstract][Full Text] [Related]  

  • 80. SPAG5 Activates PI3K/AKT Pathway and Promotes the Tumor Progression and Chemo-Resistance in Gastric Cancer.
    An J; Yang L; Pan Y; He Y; Xie H; Tao Y; Li W; Yan Y; Chen S; Liu Y; Ma X; An L; Ji D; Su Z; Sheng J
    DNA Cell Biol; 2022 Oct; 41(10):893-902. PubMed ID: 36264549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.